WHC is still in active development. Read this to understand our approach.
depiction of WEXRUCMBJFQVBZ-UHFFFAOYSA-N.svg
tripsit

pentobarbital

Check on tripsit

psychonaut

Pentobarbital

Check on psychonaut

isomerdesign

Pentobarbital

Check on isomerdesign

pubchem

Pentobarbital

Check on pubchem

druglab

Pentobarbital

Check on druglab

drugmap

Pentobarbital

Check on drugmap

wiki

Pentobarbital

Check on wiki

Data

InChI: InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)

Synonyms: Pentobarbituric acid,Mebubarbital,Sodium pentobarbital,HMS3713B10,KBio2_002266,Pentobarbital cii,NSC760434, Pentobarbiturate,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-,DTXCID003435,5-Ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione, Pentabarbital,I4744080IR,EINECS 200-983-8,novopentobarb,2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-,KBio2_004834,(+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid,PENTOBARBITAL [MI],Spectrum5_001705,Spectrum_001783,GTPL5480, Ethaminal,SCHEMBL24966, Nembutal (VAN),DSSTox_GSID_23435,NSC28708,Spectrum3_001783,Tox21_111555,CCG-39476,CHEMBL448, 5-Ethyl-5-(sec-pentyl)barbituric acid,Pentobarbitalum [INN-Latin], Pentobarbitone, Pentobarbital calcium,PENTOBARBITAL [VANDF],component of Emesert (Salt/Mix),5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione, Pentobarbital, Monosodium Salt,Q409632,Pentobarbital [USP:INN:BAN],PENTOBARBITAL [MART.],Barbituric acid, 5-ethyl-5-(1-methylbutyl)-,5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione, Rivadorm,Pentobarbitone (VAN), Pentobarbital [USP:INN], 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Continal (Salt/Mix),Pentobarbitale,PENTOBARBITAL [USP MONOGRAPH], Nebralin,Pentobarbital calcium, Mebubarbital,Neodorm,HMS2094E21,5-Ethyl-5-(1-methylbutyl)malonylurea,SR-05000001789,PENTOBARBITAL [HSDB],PENTOBARBITAL [EP MONOGRAPH], Neodorm (VAN),component of Synirin (Salt/Mix),Ethaminal, Etaminal,PENTOBARBITAL [WHO-DD],Pentobarbitale [DCIT],5-24-09-00168 (Beilstein Handbook Reference),SBI-0052713.P002,Pentobarbital 0.1 mg/ml in Methanol, Pentobarbital suppository dosage form,Nebralin,Pentobarbital (VAN),CCG-220564,DSSTox_RID_77026,Neodorm (VAN),Pentobarbiturate,(+/-)-5-ETHYL-5-(1-METHYLBUTYL)BARBITURIC ACID,DivK1c_000992, Mebumal, Neodorm,KBio2_007402,Ethyl-propylmethylcarbinylbarbituric acid,Pentobarbital, European Pharmacopoeia (EP) Reference Standard,057P561,Nembutal,SCHEMBL11114711,KBioGR_001008,Nembutal (TN), Pentobarbitalum [INN-Latin],Nembutal (VAN),SR-01000317092-2, Neodorm (new),UNII-I4744080IR,5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione,WLN: T6VMVMV FHJ FY3&1 F2, Nembutal,Phetobarbitone,Oprea1_775730,PENTOBARBITAL [ORANGE BOOK],PENTOBARBITAL [GREEN BOOK],KBio1_000992,BSPBio_003305,Oprea1_143902,CCRIS 7089,DB-056119, 5-Ethyl-5-(1-methylbutyl)malonylurea,5-Ethyl-5-(1-methylbutyl)barbituric acid,Pentobarbital,HSDB 3151,CAS-76-74-4,NCGC00344563-01,nembutal,Pentobarbital [INN],THIOPENTAL SODIUM IMPURITY B [EP IMPURITY],NCGC00096074-01,Sedalixir (Salt/Mix), Pentobarbital (VAN),57-33-0,Pentabarbital,Pentobarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,SR-01000317092,(.+/-.))-Pentobarbital, 5-Ethyl-5-(1-methylbutyl)barbituric acid, Pentobarbituric acid,SPBio_002201,Sagatal,5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Pentabarbitone,SR-05000001789-1,Pentobarbital (USP/INN),CHEBI:7983,BRD-A44448661-001-01-4,EC 200-983-8,DTXSID7023435,PENTOBARBITAL CII [USP-RS],KBioSS_002267,DB00312,BDBM50055935,5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione,Aethaminalum, (+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid, Pentobarbitale,NSC-28708, Pentobarbital (USP/INN),Neodorm (new),5-Ethyl-5-(sec-pentyl)barbituric acid,Mebumal,C07422, 5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione, Pentobarbitale [DCIT],NCGC00096074-02,pentobarbital, Pentobarbitone (VAN),Barbituric acid, 5-ethyl-5-(2-pentyl)-,5-Ethyl-5-(1-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione,2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5-ETHYL-5-(1-METHYLBUTYL)-, (+/-)-,AKOS000277861,DSSTox_CID_3435, Ethyl-propylmethylcarbinylbarbituric acid,Pentobarbital 1.0 mg/ml in Methanol,STL367899,NINDS_000992, Pentabarbitone,5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione,HMS503G05,NSC 28708,IDI1_000992,SPECTRUM1900006,Dorsital,Spectrum4_000574, Nembutal (TN),Pentobarbitone,Pentobarbitalum, Pentobarbitalum,Spectrum2_001991,(plusmn)-pentobarbital,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, Dorsital,Pentobarbital, United States Pharmacopeia (USP) Reference Standard,NSC-760434,BRN 0087067,76-74-4,D00499,KBio3_002807,Rivadorm, 5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione,(RS)-pentobarbital,Pharmakon1600-01900006

Estimated data

Solubility: -2.079 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 37.5% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.